Summary
A pharmacological network of “component/target/pathway” for Rhizoma coptidis against type 2 diabetes (T2D) was established by network-pharmacology, and the active components of Rhizoma coptidis and its mechanism were explored. A literature-based and database study of the components of Rhizoma coptidis was carried out and screened by ADME parameters. The targets of Rhizoma coptidis were predicted by the ligand similarity method. Related pathways were analyzed with databases, and software was used to construct a “component/target/path” network. The mechanism was further confirmed by GEO database with R software. A total of 12 active components were screened from Rhizoma coptidis, involving 57 targets including MAPK1, STAT3, INSR, and 38 signaling pathways were associated with T2D. Related signaling pathways included essential pathways for T2D such as insulin resistance, and pathways that had indirect effect on T2D. It was suggested that Rhizoma coptidis may exert its effects against T2D through multi-component, multi-target, and multi-pathway forms.
Similar content being viewed by others
References
Tang J, Feng Y, Tsao S, et al. Berberine and Coptidis Rhizoma as novel antineoplastic agents: A review of traditional use and biomedical investigations. J Ethnopharmacol, 2009,126(1):5–17
Meng FC, Wu ZF, Yin ZQ, et al. Coptidis rhizoma and its main bioactive components: recent advances in chemical investigation, quality evaluation and pharmacological activity. Chin Med, 2018,13(1):13
Jaacks LM, Siegel KR, Gujral UP, et al. Type 2 diabetes: A 21st century epidemic. Best Pract Res Clin Endocrinol Metab, 2016,30(3):331–343
Tong XL, Dong L, Chen L, et al. Treatment of Diabetes Using Traditional Chinese Medicine: Past, Present and Future. Am J Chin Med, 2012,40(05):877–886
Wang H, Mu W, Shang H, et al. The antihyperglycemic effects of Rhizoma Coptidis and mechanism of actions: a review of systematic reviews and pharmacological research. BioMed Res Int, 2014,2014:98093
Zhao X, Feng A, Huang Q, et al. Effect of Rhizoma Coptidis on Bax and Bcl-2 Protein Expression in Diabetic Rats with Cerebral Ischemia Reperfusion. Pract Geriat, 2017,31(11):1021–1024
Lee YS, Kim WS, Kim KH, et al. Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase with Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States. Diabetes, 2006,55(8):2256
Xia X, Yan J, Shen Y, et al. Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis. PLoS One, 2011,6(2):e16556
Lu SS, Yu YL, Zhu HJ, et al. Berberine promotes glucagon-like peptide-1 (7–36) amide secretion in streptozotocin-induced diabetic rats. J Endocrinol, 2009, 200(2):159–165
Hopkins AL. Network pharmacology. Nature Biotechnol, 2007,25:1110
Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nature Chem Biol, 2008,4:682
Li S, Zhang B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Natural Med, 2013,11(2):110–120
Li FS, Weng JK. Demystifying traditional herbal medicine with modern approach. Nature Plants, 2017, 3:17 109
Barnes J. Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality. Br J Clin Pharmacol, 2003,55(3):226–233
Gu J, Gui Y, Chen L, et al. Use of Natural Products as Chemical Library for Drug Discovery and Network Pharmacology. PLoS One, 2013,8(4):e62839
Yi F, Li L, Xu LJ, et al. In silico approach in reveal traditional medicine plants pharmacological material basis. Chin Med, 2018,13(1):33
Huang WY, Dong H. Coptidis Rhizoma-Contained Traditional Formulae for Insomnia: A Potential to Prevent Diabetes?. Chin J Integr Med, 2018,24(10):785–788
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
The authors declare that they have no conflicts of interest with thecontents of this article.
Additional information
This project was supported by National Natural Science Foundation of China (No. 31570343).
Rights and permissions
About this article
Cite this article
Sun, Y., Xiong, Yy., Wu, Hz. et al. Active Ingredients and Mechanism of Action of Rhizoma Coptidis against Type 2 Diabetes Based on Network-Pharmacology and Bioinformatics. CURR MED SCI 40, 257–264 (2020). https://doi.org/10.1007/s11596-020-2182-4
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-020-2182-4